A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: Implication for immunotherapy of human hepatocellular carcinoma
Yoshinari Atarashi, Satoshi Yasumura, Shuji Nambu, Yukimatsu Yoshio, Jun Murakami, Terumi Takahara, Kiyohiro Higuchi, Akiharu Watanabe, Keizo Miyata, Masanari Kato – 30 December 2003 – Although treatment for hepatocellular carcinoma (HCC) has recently improved, most patients still relapse and die from this disease. The development of new therapeutic and preventive strategies for HCC is, therefore, required. A novel mutant protein (mutein) of human tumor necrosis factor alfa (TNF‐α mutein F4614,1SSSRGDSD··· 29V ··· 155L) was developed to decrease several adverse effects of TNF‐α.